Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine - 1

Completed · Phase 1

Conditions studied: Cocaine-Related Disorders

In brief

The purpose of this study is to assess potential interactions between intravenous (i.v.) cocaine and atomoxetine (Strattera) administered orally in four escalating doses.

Key facts

Study ID

NCT00265265

Run by

National Institute on Drug Abuse (NIDA)

People needed

16

Starts

2005-08-01

Last updated by the study team

2017-01-12

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18-45 years of age who are not seeking treatment at the time of the study
• Must be able to provide written informed consent
• Must be within 20 percent of ideal body weight and weigh at least 45 kg
• Must meet DSM0IV diagnostic criteria for cocaine abuse or dependence
• Must currently be using cocaine as confirmed by a positive BE
• If female and of child bearing potential, must agree to the use of birth control

You may not qualify if…

• please contact the site directly for more information

Where it is running

• Uniformed Services University of Health Science — Bethesda, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.